Chrisoula D. Scopa
Patra, ESYE23, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Expression Of Intracellular Components of the NF-κB Alternative Pathway (NF-κB2, RelB, NIK and Bcl3) is Associated With Clinical Outcome of NSCLC Patients.
Journal: Scientific reports
Published: May 16, 2019
Expression of Immune System-Related Membrane Receptors CD40, RANK, BAFFR and LTβR is Associated with Clinical Outcome of Operated Non-Small-Cell Lung Cancer Patients.
Journal: Journal of clinical medicine
Published: April 23, 2019
HER Family Protein Expression in a Greek Population with Gastric Cancer. A Retrospective Hellenic Cooperative Oncology Group Study.
Journal: Anticancer research
Published: January 26, 2016
Significance of PIK3CA Mutations in Patients with Early Breast Cancer Treated with Adjuvant Chemotherapy: A Hellenic Cooperative Oncology Group (HeCOG) Study.
Journal: PloS one
Published: July 24, 2015
Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial.
Journal: Anticancer research
Published: July 01, 2015
Expression of the microRNA regulators Drosha, Dicer and Ago2 in non-small cell lung carcinomas.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: May 26, 2015
Expression of phosphorylated Akt, mTOR and MAPK in type I endometrial carcinoma: clinical significance.
Journal: Anticancer research
Published: April 12, 2015
Impact of tumor angiogenic profile on the outcome of patients with metastatic breast carcinoma treated with weekly docetaxel. A Hellenic Cooperative Oncology Group (HeCOG) study.
Journal: Histology and histopathology
Published: March 26, 2015
Variant of BCL3 gene is strongly associated with five-year survival of non-small-cell lung cancer patients.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 05, 2015
Targeted pathways in breast cancer: molecular and protein markers guiding therapeutic decisions.
Journal: Current molecular pharmacology
Published: September 04, 2014
Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer.
Journal: BMC cancer
Published: July 06, 2014
Last Updated: 09/26/2026